Reported per clinical trial(b)(4): (b)(6) 2013 - subject patient underwent laparoscopic midline hernia repair (24cm x 14cm) procedure during which a bard/davol ventralight st mesh was implanted with suture.Full skin closure was achieved using adhesive skin closure.The patient was discharged to home on (b)(6) 2013.It was noted that the subject experienced abdominal pain at every follow-up after the procedure.(b)(6) 2015 - subject patient presented with abdominal pain and diagnosed with adhesions and underwent exploratory laparoscopic surgery for lysis of adhesions.The patient discharged from the hospital on (b)(6) 2015.Per the study clinician, the reported adverse event has been assessed as moderate in severity, possibly related to the study device, definitely related to the procedure.The outcome for this ae is reported has recovered/resolved.
|
As reported, about twenty months post-implant of the ventralight st mesh, the patient was diagnosed with abdominal pain and adhesions and underwent surgery for lysis of adhesions.As reported, the ae has resolved.The clinician has assessed the patient¿s postoperative course as being "possibly" related to the study device and definitely related to the index procedure, however, based on the information provided, no conclusion can be made.Adhesions is a known inherent risk of hernia repair surgery.The adverse reactions section of the instructions-for-use, supplied with the device lists adhesions as a possible complication.To date, this is the only reported complaint for this manufacturing lot.Not returned - remains implanted.
|